Developing Novel Immunogens for an Effective, Safe Alzheimer’s Disease Vaccine

Publisher： Karger

E-ISSN： 1660-2862|2|5|267-272

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.2, Iss.5, 2006-02, pp. : 267-272

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alzheimer’s as a metabolic disease

By Demetrius Lloyd   Driver Jane  

Biogerontology, Vol. 14, Iss. 6, 2013-12 ,pp. : 641-649

Springer Publishing Company

Access to resources Recommend Favorite

Retromers in Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 10, Iss. 1-4, 2012-03 ,pp. : 116-121

Karger

Access to resources Recommend Favorite

The role of caspases in Alzheimer’s disease; potential novel therapeutic opportunities

By Rohn Troy  

Apoptosis, Vol. 15, Iss. 11, 2010-11 ,pp. : 1403-1409

Springer Publishing Company

Access to resources Recommend Favorite

Delivery of a DNA Vaccine for Alzheimer’s Disease by Electroporation versus Gene Gun Generates Potent and Similar Immune Responses

By  

Neurodegenerative Diseases, Vol. 10, Iss. 1-4, 2012-02 ,pp. : 261-264

Karger

Access to resources Recommend Favorite

Autophagy Dysfunction in Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 7, Iss. 4, 2010-05 ,pp. : 265-271

Karger

Access to resources Recommend Favorite